STVN
Stevanato Group SpA
NYSE: STVN · HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES
$18.28
+0.27% today
Updated 2026-05-11
Market cap
$4.99B
P/E ratio
30.47
P/S ratio
4.15x
EPS (TTM)
$0.60
Dividend yield
—
52W range
$13 – $28
Volume
0.6M
Stevanato Group SpA (STVN) Financial statements
SEC filings — annual and quarterly data.
Profit margin
11.70%
Operating margin
14.20%
ROE
9.59%
ROA
5.27%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2019 | $536.54M | $39.20M | 25.72% | 11.60% | 7.31% |
| 2020 | $662.04M | $78.51M | 29.33% | 15.57% | 11.86% |
| 2021 | $843.92M | $134.32M | 31.45% | 19.22% | 15.92% |
| 2022 | $983.68M | $142.85M | 32.51% | 19.56% | 14.52% |
| 2023 | $1.09B | $145.63M | 31.32% | 18.49% | 13.42% |
| 2024 | $1.10B | $117.78M | 27.38% | 14.60% | 10.67% |
| 2025 | $1.14B | $134.28M | 28.99% | 16.07% | 11.78% |